Skip to main content
Top
Published in: Advances in Gerontology 1/2020

01-01-2020 | Kidney Cancer

Asymptomatic Kidney Tumors in Elderly Patients: Review of Treatment Approaches in Russia and Western Countries

Authors: Sh. Kh. Gantsev, A. A. Khmelevskiy, K. Sh. Gantsev, Y. N. Khrizman

Published in: Advances in Gerontology | Issue 1/2020

Login to get access

Abstract

This paper analyzes and evaluates the results of recent research on active observation strategies in North America and Europe. There are enough grounds for a more active implementation and use of this approach, which is permissible in a strictly selected category of patients, namely, in elderly patients. In Russia at the moment, the personalized approach to treatment is underdeveloped. Patients over 60–65 years old are a significant group of patients with kidney tumors. In the determination of the tactics of the care of these patients, it is important to understand that this contingent has a greater risk of death from comorbidities than the relatively low risk of death from kidney cancer. The improvement of modern diagnostic methods and the introduction of screening programs have led to a significant increase in the frequency of the detection of small kidney tumors in elderly patients. The results of studies comparing radical approaches to treatment and observation suggest the widespread adoption of a strategy for the active monitoring of asymptomatic kidney tumors in the elderly in Russian oncological practice.
Literature
1.
go back to reference Alekseev, B.Ya., Volkova, M.I., Kalpinskii, A.S., et al., Klinicheskie rekomendatsii po diagnostike i lecheniyu raka pochki (Clinical Recommendations for Diagnostics and Treatment of Bud Cancer), Moscow, 2014. Alekseev, B.Ya., Volkova, M.I., Kalpinskii, A.S., et al., Klinicheskie rekomendatsii po diagnostike i lecheniyu raka pochki (Clinical Recommendations for Diagnostics and Treatment of Bud Cancer), Moscow, 2014.
2.
go back to reference Anisimov, V.N. and Belyaev, A.M., Onkogerontologiya: rukovodstvo dlya vrachei (Oncogerontology: Manual for Physicians), St. Petersburg, 2017. Anisimov, V.N. and Belyaev, A.M., Onkogerontologiya: rukovodstvo dlya vrachei (Oncogerontology: Manual for Physicians), St. Petersburg, 2017.
3.
go back to reference Gantsev, Sh.Kh., Kzyrgalin, Sh.R., and Gantsev, K.Sh., Surgery in oncology: from advanced surgery to minimally invasive methods, Prakt. Onkol., 2017, vol. 18, no. 4, pp. 355–360. Gantsev, Sh.Kh., Kzyrgalin, Sh.R., and Gantsev, K.Sh., Surgery in oncology: from advanced surgery to minimally invasive methods, Prakt. Onkol., 2017, vol. 18, no. 4, pp. 355–360.
4.
go back to reference Zlokachestvennye novoobrazovaniya v Rossii v 2017 g.: zabolevaemost’ i smertnost’ (Rate of Malignant Neoplasms in Russia in 2017: Morbidity and Mortality), Kaprin, A.D. et al., Eds., Moscow: Mosk. Nauchno-Issled. Onkol. Inst. im. P.A. Gertsena, 2018. Zlokachestvennye novoobrazovaniya v Rossii v 2017 g.: zabolevaemost’ i smertnost’ (Rate of Malignant Neoplasms in Russia in 2017: Morbidity and Mortality), Kaprin, A.D. et al., Eds., Moscow: Mosk. Nauchno-Issled. Onkol. Inst. im. P.A. Gertsena, 2018.
5.
go back to reference Abouassaly, R., Lane, B.R., and Novick, A.C., Active surveillance of renal masses in elderly patients, J. Urol., 2008, vol. 180, pp. 505–508.CrossRef Abouassaly, R., Lane, B.R., and Novick, A.C., Active surveillance of renal masses in elderly patients, J. Urol., 2008, vol. 180, pp. 505–508.CrossRef
6.
go back to reference Abou Youssif, T., Kassouf, W., Steinberg, J., et al., Active surveillance for selected patients with renal masses: updated results with long-term follow-up, Cancer, 2007, vol. 110, pp. 1010–1014.CrossRef Abou Youssif, T., Kassouf, W., Steinberg, J., et al., Active surveillance for selected patients with renal masses: updated results with long-term follow-up, Cancer, 2007, vol. 110, pp. 1010–1014.CrossRef
7.
go back to reference Beisland, C., Hjelle, K.M., Reisaeter, L.A., et al., Observation should be considered as an alternative in management of renal masses in older and comorbid patients, Eur. Urol., 2009, vol. 55, pp. 1419–1429.CrossRef Beisland, C., Hjelle, K.M., Reisaeter, L.A., et al., Observation should be considered as an alternative in management of renal masses in older and comorbid patients, Eur. Urol., 2009, vol. 55, pp. 1419–1429.CrossRef
8.
go back to reference Crispen, P.L., Wong, Y.N., Greenberg, R.E., et al., Predicting growth of solid renal masses under active surveillance, Urol. Oncol., 2008, vol. 26, pp. 555–559.CrossRef Crispen, P.L., Wong, Y.N., Greenberg, R.E., et al., Predicting growth of solid renal masses under active surveillance, Urol. Oncol., 2008, vol. 26, pp. 555–559.CrossRef
9.
go back to reference Crispen, P.L., Viterbo, R., Boorjian, S.A., et al., Natural history, growth kinetics and outcomes of untreated clinically localized renal tumors under active surveillance, Cancer, 2009, vol. 115, pp. 2844–2852.CrossRef Crispen, P.L., Viterbo, R., Boorjian, S.A., et al., Natural history, growth kinetics and outcomes of untreated clinically localized renal tumors under active surveillance, Cancer, 2009, vol. 115, pp. 2844–2852.CrossRef
10.
go back to reference Crispen, P.L., Viterbo, R., Fox, E.B., et al., Delayed intervention of sporadic renal masses undergoing active surveillance, Cancer, 2008, vol. 112, pp. 1051–1057.CrossRef Crispen, P.L., Viterbo, R., Fox, E.B., et al., Delayed intervention of sporadic renal masses undergoing active surveillance, Cancer, 2008, vol. 112, pp. 1051–1057.CrossRef
11.
go back to reference Chawla S.N., Crispen, P.L., Hanlon, A.L., et al., The natural history of observed enhancing renal masses: meta-analysis and review of the world literature, J. Urol., 2006, vol. 175, pp. 425–431.CrossRef Chawla S.N., Crispen, P.L., Hanlon, A.L., et al., The natural history of observed enhancing renal masses: meta-analysis and review of the world literature, J. Urol., 2006, vol. 175, pp. 425–431.CrossRef
12.
go back to reference Cancer research UK, 2017. https://www.cancerresearchuk.org. Cancer research UK, 2017. https://​www.​cancerresearchuk​.​org.​
13.
go back to reference Ferlay, J., Shin, H.R., Bray, F., et al., Estimates of worldwide burden of cancer in 2008, J. Cancer, 2010, vol. 15, pp. 2893–2917. Ferlay, J., Shin, H.R., Bray, F., et al., Estimates of worldwide burden of cancer in 2008, J. Cancer, 2010, vol. 15, pp. 2893–2917.
14.
go back to reference Ferlay, J., Parkin, D.M., and Steliarova-Foucher, E., Estimates of cancer incidence and mortality in Europe in 2008, Eur. J. Cancer, 2010, vol. 46, pp. 765–781.CrossRef Ferlay, J., Parkin, D.M., and Steliarova-Foucher, E., Estimates of cancer incidence and mortality in Europe in 2008, Eur. J. Cancer, 2010, vol. 46, pp. 765–781.CrossRef
15.
go back to reference Hollingsworth, J.M., Miller, D.C., Daignault, S., et al., Rising incidence of small renal masses: a need to reassess treatment effect, J. Nat. Cancer Inst., 2006, vol. 98, no. 18, pp. 1331–1334.CrossRef Hollingsworth, J.M., Miller, D.C., Daignault, S., et al., Rising incidence of small renal masses: a need to reassess treatment effect, J. Nat. Cancer Inst., 2006, vol. 98, no. 18, pp. 1331–1334.CrossRef
16.
go back to reference Jewett, M.A.S., Finelli, A., Link, I., et al., Active surveillance of small renal masses: a prospective muti-center Canadian Uro-Oncology Group trial, J. Urol., 2009, vol. 181, no. 4, p. 320.CrossRef Jewett, M.A.S., Finelli, A., Link, I., et al., Active surveillance of small renal masses: a prospective muti-center Canadian Uro-Oncology Group trial, J. Urol., 2009, vol. 181, no. 4, p. 320.CrossRef
17.
go back to reference Jewett, M.A.S., Mattar, K., Basiuk, J., et al., Active surveillance of small renal masses: progression patterns of early stage kidney cancer, Eur. Urol., 2011, vol. 60, pp. 39–44.CrossRef Jewett, M.A.S., Mattar, K., Basiuk, J., et al., Active surveillance of small renal masses: progression patterns of early stage kidney cancer, Eur. Urol., 2011, vol. 60, pp. 39–44.CrossRef
18.
go back to reference Jewett, M.A.S., Finelli, A., Link, I., et al., Active surveillance of small renal masses: a prospective muti-center Canadian Uro-Oncology Group trial, J. Urol., 2009, vol. 181, no. 4, p. 320.CrossRef Jewett, M.A.S., Finelli, A., Link, I., et al., Active surveillance of small renal masses: a prospective muti-center Canadian Uro-Oncology Group trial, J. Urol., 2009, vol. 181, no. 4, p. 320.CrossRef
19.
go back to reference Jewett, M.A.S., The motion: surveillance is an option for renal cancer, Eur. Urol., 2006, vol. 50, pp. 1363–1366.CrossRef Jewett, M.A.S., The motion: surveillance is an option for renal cancer, Eur. Urol., 2006, vol. 50, pp. 1363–1366.CrossRef
20.
go back to reference Jemal, A., Siegel, R., Xu, J., et al., Cancer statistics 2010, CA Cancer J. Clin., 2010, vol. 60, pp. 277–300.CrossRef Jemal, A., Siegel, R., Xu, J., et al., Cancer statistics 2010, CA Cancer J. Clin., 2010, vol. 60, pp. 277–300.CrossRef
21.
go back to reference Jemal, A., Thun, M.J., Ries, L.A.G., et al., Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control, J. Nat. Cancer Inst., 2008, vol. 100, pp. 1672–1694.CrossRef Jemal, A., Thun, M.J., Ries, L.A.G., et al., Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control, J. Nat. Cancer Inst., 2008, vol. 100, pp. 1672–1694.CrossRef
22.
go back to reference Karim-Kos, H.E., De Vries, E., Soerjomataram, I., et al., Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s, Eur. J. Cancer, 2008, vol. 44, pp. 1345–1389.CrossRef Karim-Kos, H.E., De Vries, E., Soerjomataram, I., et al., Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s, Eur. J. Cancer, 2008, vol. 44, pp. 1345–1389.CrossRef
23.
go back to reference Lane, B.R., Abouassaly, R., Gao, T., et al., Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older, Cancer, 2010, vol. 116, pp. 3119–3126.CrossRef Lane, B.R., Abouassaly, R., Gao, T., et al., Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older, Cancer, 2010, vol. 116, pp. 3119–3126.CrossRef
24.
go back to reference Luciani, L.G., Cestari, R., and Tallarigo, C., Incidental renal cell carcinoma—age and stage characterization and clinical implications: study of 1092 patients (1982–1997), Urology, 2000, vol. 56, pp. 58–62.CrossRef Luciani, L.G., Cestari, R., and Tallarigo, C., Incidental renal cell carcinoma—age and stage characterization and clinical implications: study of 1092 patients (1982–1997), Urology, 2000, vol. 56, pp. 58–62.CrossRef
25.
go back to reference Ljungberg, B., Campbell, S.C., Choi, H.Y., et al., The epidemiology of renal cell carcinoma, Eur. Urol., 2011, vol. 60, no. 4, pp. 615–621.CrossRef Ljungberg, B., Campbell, S.C., Choi, H.Y., et al., The epidemiology of renal cell carcinoma, Eur. Urol., 2011, vol. 60, no. 4, pp. 615–621.CrossRef
26.
go back to reference Levi, F., Ferlay, J., Galeone, C., et al., The changing pattern of kidney cancer incidence and mortality in Europe, BJU Int., 2008, vol. 101, no. 8, pp. 949–958.CrossRef Levi, F., Ferlay, J., Galeone, C., et al., The changing pattern of kidney cancer incidence and mortality in Europe, BJU Int., 2008, vol. 101, no. 8, pp. 949–958.CrossRef
27.
go back to reference Mason, R.J., Abdolell, M., and Trottier, G., Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance, Eur. Urol., 2011, vol. 59, pp. 863–867.CrossRef Mason, R.J., Abdolell, M., and Trottier, G., Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance, Eur. Urol., 2011, vol. 59, pp. 863–867.CrossRef
28.
go back to reference Proc. 4th Annual Genitourinary Cancers Symp., February 16, 2013, Orlando, 2013. Proc. 4th Annual Genitourinary Cancers Symp., February 16, 2013, Orlando, 2013.
29.
go back to reference Rosales, J.C., Haramis, G., Moreno, J., et al., Active surveillance for renal cortical neoplasms, J. Urol., 2010, vol. 183, pp. 1698–1702.CrossRef Rosales, J.C., Haramis, G., Moreno, J., et al., Active surveillance for renal cortical neoplasms, J. Urol., 2010, vol. 183, pp. 1698–1702.CrossRef
30.
go back to reference Stafford, H.S., Saltzstein, S.L., Shimasaki, S., et al., Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival, J. Urol., 2008, vol. 179, pp. 1704–1708.CrossRef Stafford, H.S., Saltzstein, S.L., Shimasaki, S., et al., Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival, J. Urol., 2008, vol. 179, pp. 1704–1708.CrossRef
31.
go back to reference Siegel, R., Naishadham, D., and Jemal, A., Cancer statistics 2013, CA Cancer J. Clin., 2013, vol. 63, pp. 11–30.CrossRef Siegel, R., Naishadham, D., and Jemal, A., Cancer statistics 2013, CA Cancer J. Clin., 2013, vol. 63, pp. 11–30.CrossRef
32.
go back to reference Yates, D.R. and Rouprét, M., Small renal mass and low-risk prostate cancer: any more for active surveillance?, Eur. Urol., 2011, vol. 60, pp. 45–47.CrossRef Yates, D.R. and Rouprét, M., Small renal mass and low-risk prostate cancer: any more for active surveillance?, Eur. Urol., 2011, vol. 60, pp. 45–47.CrossRef
Metadata
Title
Asymptomatic Kidney Tumors in Elderly Patients: Review of Treatment Approaches in Russia and Western Countries
Authors
Sh. Kh. Gantsev
A. A. Khmelevskiy
K. Sh. Gantsev
Y. N. Khrizman
Publication date
01-01-2020
Publisher
Pleiades Publishing
Published in
Advances in Gerontology / Issue 1/2020
Print ISSN: 2079-0570
Electronic ISSN: 2079-0589
DOI
https://doi.org/10.1134/S2079057020010051

Other articles of this Issue 1/2020

Advances in Gerontology 1/2020 Go to the issue